-
Je něco špatně v tomto záznamu ?
Effects of Spinal Cord Stimulation on Cardiac Sympathetic Nerve Activity in Patients with Heart Failure
J. Naar, D. Jaye, C. Linde, P. Neužil, P. Doškář, F. Málek, F. Braunschweig, LH. Lund, L. Mortensen, B. Linderoth, G. Lind, D. Bone, AJ. Scholte, F. Kueffer, J. Koehler, K. Shahgaldi, O. Lang, M. Ståhlberg,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, randomizované kontrolované studie
NLK
CINAHL Plus with Full Text (EBSCOhost)
od 1978-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 1978-01-01 do Před 1 rokem
PubMed
28206674
DOI
10.1111/pace.13050
Knihovny.cz E-zdroje
- MeSH
- lidé MeSH
- mícha diagnostické zobrazování patofyziologie MeSH
- míšní stimulace metody MeSH
- senioři MeSH
- srdce diagnostické zobrazování inervace patofyziologie MeSH
- srdeční selhání patofyziologie terapie MeSH
- sympatický nervový systém patofyziologie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- randomizované kontrolované studie MeSH
BACKGROUND: Spinal cord stimulation (SCS) reduces sympathetic activity in animal models of heart failure with reduced ejection fraction (HF) but limited data exist of SCS in patients with HF. The aim of the present study was to test the primary hypothesis that SCS reduces cardiac sympathetic nerve activity in HF patients. Secondary hypotheses were that SCS improves left ventricular function and dimension, exercise capacity, and clinical variables relevant to HF. METHODS: HF patients with a SCS device previously participating in the DEFEAT-HF trial were included in this crossover study with 6-week intervention periods (SCS-ON and SCS-OFF). SCS (50 Hz, 210-μs pulse duration, aiming at T2-T4 segments) was delivered for 12 hours daily. Indices of myocardial sympathetic neuronal function (heart-to-mediastinum ratio, HMR) and activity (washout rate, WR) were assessed using123I-metaiodobenzylguanidine (MIBG) scintigraphy. Echocardiography, exercise testing, and clinical data collection were also performed. RESULTS: We included 13 patients (65.3 ± 8.0 years, nine males) and MIBG scintigraphy data were available in 10. HMR was not different comparing SCS-ON (1.37 ± 0.16) and SCS-OFF (1.41 ± 0.21, P = 0.46). WR was also unchanged comparing SCS-ON (41.5 ± 5.3) and SCS-OFF (39.1 ± 5.8, P = 0.30). Similarly, average New York Heart Association class (2.4 ± 0.5 vs 2.3 ± 0.6, P = 0.34), quality of life score (24 ± 16 vs 24 ± 16, P = 0.94), and left ventricular dimension and function as well as exercise capacity were all unchanged comparing SCS-ON and SCS-OFF. CONCLUSION: In patients with HF, SCS (12 hours daily, targeting the T2-T4 segments of the spinal cord) does not appear to influence cardiac sympathetic neuronal activity or function as assessed by MIBG scintigraphy.
Cardiac Rhythm and Heart Failure Medtronic Plc Minneapolis Minnesota
Department of Cardiology Leiden University Medical Center Leiden the Netherlands
Department of Cardiology Na Homolce Hospital Prague Czech Republic
Department of Clinical Physiology Sunderby Hospital Luleå Sweden
Department of Nuclear Medicine University Hospital Královské Vinohrady Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010797
- 003
- CZ-PrNML
- 005
- 20180418150123.0
- 007
- ta
- 008
- 180404s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/pace.13050 $2 doi
- 035 __
- $a (PubMed)28206674
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Naar, Jan $u Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.
- 245 10
- $a Effects of Spinal Cord Stimulation on Cardiac Sympathetic Nerve Activity in Patients with Heart Failure / $c J. Naar, D. Jaye, C. Linde, P. Neužil, P. Doškář, F. Málek, F. Braunschweig, LH. Lund, L. Mortensen, B. Linderoth, G. Lind, D. Bone, AJ. Scholte, F. Kueffer, J. Koehler, K. Shahgaldi, O. Lang, M. Ståhlberg,
- 520 9_
- $a BACKGROUND: Spinal cord stimulation (SCS) reduces sympathetic activity in animal models of heart failure with reduced ejection fraction (HF) but limited data exist of SCS in patients with HF. The aim of the present study was to test the primary hypothesis that SCS reduces cardiac sympathetic nerve activity in HF patients. Secondary hypotheses were that SCS improves left ventricular function and dimension, exercise capacity, and clinical variables relevant to HF. METHODS: HF patients with a SCS device previously participating in the DEFEAT-HF trial were included in this crossover study with 6-week intervention periods (SCS-ON and SCS-OFF). SCS (50 Hz, 210-μs pulse duration, aiming at T2-T4 segments) was delivered for 12 hours daily. Indices of myocardial sympathetic neuronal function (heart-to-mediastinum ratio, HMR) and activity (washout rate, WR) were assessed using123I-metaiodobenzylguanidine (MIBG) scintigraphy. Echocardiography, exercise testing, and clinical data collection were also performed. RESULTS: We included 13 patients (65.3 ± 8.0 years, nine males) and MIBG scintigraphy data were available in 10. HMR was not different comparing SCS-ON (1.37 ± 0.16) and SCS-OFF (1.41 ± 0.21, P = 0.46). WR was also unchanged comparing SCS-ON (41.5 ± 5.3) and SCS-OFF (39.1 ± 5.8, P = 0.30). Similarly, average New York Heart Association class (2.4 ± 0.5 vs 2.3 ± 0.6, P = 0.34), quality of life score (24 ± 16 vs 24 ± 16, P = 0.94), and left ventricular dimension and function as well as exercise capacity were all unchanged comparing SCS-ON and SCS-OFF. CONCLUSION: In patients with HF, SCS (12 hours daily, targeting the T2-T4 segments of the spinal cord) does not appear to influence cardiac sympathetic neuronal activity or function as assessed by MIBG scintigraphy.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdce $x diagnostické zobrazování $x inervace $x patofyziologie $7 D006321
- 650 _2
- $a srdeční selhání $x patofyziologie $x terapie $7 D006333
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mícha $x diagnostické zobrazování $x patofyziologie $7 D013116
- 650 _2
- $a míšní stimulace $x metody $7 D062187
- 650 _2
- $a sympatický nervový systém $x patofyziologie $7 D013564
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a Jaye, Deborah $u Cardiac Rhythm and Heart Failure, Medtronic Plc, Minneapolis, Minnesota.
- 700 1_
- $a Linde, Cecilia $u Department of Medicine, Solna, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
- 700 1_
- $a Neužil, Petr $u Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.
- 700 1_
- $a Doškář, Petr $u Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.
- 700 1_
- $a Málek, Filip $u Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.
- 700 1_
- $a Braunschweig, Frieder $u Department of Medicine, Solna, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
- 700 1_
- $a Lund, Lars H $u Department of Medicine, Solna, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
- 700 1_
- $a Mortensen, Lars $u Department of Medicine, Solna, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
- 700 1_
- $a Linderoth, Bengt $u Department of Clinical Neuroscience, Karolinska Institutet, and Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.
- 700 1_
- $a Lind, Göran $u Department of Clinical Neuroscience, Karolinska Institutet, and Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.
- 700 1_
- $a Bone, Dianna $u Department of Molecular Medicine and Surgery, Karolinska Institutet, and Department of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden.
- 700 1_
- $a Scholte, Arthur J $u Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
- 700 1_
- $a Kueffer, Fred $u Cardiac Rhythm and Heart Failure, Medtronic Plc, Minneapolis, Minnesota.
- 700 1_
- $a Koehler, Jodi $u Cardiac Rhythm and Heart Failure, Medtronic Plc, Minneapolis, Minnesota.
- 700 1_
- $a Shahgaldi, Kambiz $u Department of Clinical Physiology, Sunderby Hospital, Luleå, Sweden.
- 700 1_
- $a Lang, Otto $u Department of Nuclear Medicine, University Hospital Královské Vinohrady, Prague, Czech Republic.
- 700 1_
- $a Ståhlberg, Marcus $u Department of Medicine, Solna, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
- 773 0_
- $w MED00003671 $t Pacing and clinical electrophysiology PACE $x 1540-8159 $g Roč. 40, č. 5 (2017), s. 504-513
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28206674 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180418150223 $b ABA008
- 999 __
- $a ok $b bmc $g 1288282 $s 1007609
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 40 $c 5 $d 504-513 $e 20170323 $i 1540-8159 $m Pacing and clinical electrophysiology $n Pacing Clin Electrophysiol $x MED00003671
- LZP __
- $a Pubmed-20180404